ABMC - American Bio Medica Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
1.0200
-0.0200 (-1.92%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
    9M+
Previous Close1.0400
Open1.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.9401 - 1.0700
52 Week Range0.0600 - 1.2600
Volume427,090
Avg. Volume769,988
Market Cap36.564M
Beta (5Y Monthly)-0.84
PE Ratio (TTM)N/A
EPS (TTM)-0.0210
Earnings DateAug 12, 2020 - Aug 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • ACCESSWIRE

    ABMC Reports Fourth Quarter and Year End 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / June 26, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the fourth quarter and year ended December 31, 2019. Chief Executive ...

  • ACCESSWIRE

    ABMC Offers Rapid Test for Covid-19

    KINDERHOOK, NY / ACCESSWIRE / March 23, 2020 / American Bio Medica Corporation (OTC PINK:ABMC), a manufacturer of accurate, cost-effective immunoassay test kits, announced today that it began offering on March 17, 2020, via a distribution partnership, a Rapid Test to detect Covid-19 in whole blood, serum or plasma. The test has not yet been reviewed by the U.S. Food and Drug Administration (FDA), but is being offered under the March 16, 2020 guidance set forth by the FDA. To place an order, customers can call (800) 227-2343, or (518) 758-8158 outside the United States or, contact the company via email at COVID19@abmc.com.

  • ACCESSWIRE

    ABMC Reports Third Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / November 14, 2019 / American Bio Medica Corporation (OTC PINK:ABMC) today announced financial results for the three and nine months ended September 30, 2019. Chief Executive ...

  • ACCESSWIRE

    ABMC Reports Second Quarter 2019 Results

    KINDERHOOK, NY / ACCESSWIRE / August 14, 2019 / American Bio Medica Corporation ( OTC PINK:ABMC ) today announced financial results for the three and six months ended June 30, 2019. Chief Executive Officer ...